BRAF and neoplasm: BRAF p.V600E positive and negative tumors were not significantly different based on tumor size (Table 1), with BRAF p.V600E positivity in 77% of tumors ≤ 1 cm, 82% of tumors > 1 and ≤ 2 cm, 78% of tumors > 2 and ≤ 4 cm, and 72% of tumors > 4 cm (Table 3).